ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,552Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 161

$552K Total Retail Price of All Prescriptions

Rank: 2 out of 161

321 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 321 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,280 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 557 528 1 1
POTASSIUM CHLORIDE 447 429 2 11
FUROSEMIDE 428 408 3 7
OMEPRAZOLE 389 348 4 3
LOSARTAN POTASSIUM 364 350 5 17
SIMVASTATIN 306 252 6 2
AMLODIPINE BESYLATE 267 253 7 5
ALLOPURINOL 202 202 8 28
GABAPENTIN 197 172 9 15
AVODART 195 183 10 60
METOPROLOL TARTRATE 187 183 11 12
METFORMIN HCL 185 181 12 9
HYDROCODONE-ACETAMINOPHEN 179 107 S3 13 6
LISINOPRIL 179 153 13 4
TRAMADOL HCL 176 152 15 16
PANTOPRAZOLE SODIUM 171 130 16 50
WARFARIN SODIUM 169 158 17 8
TAMSULOSIN HCL 166 153 18 24
SERTRALINE HCL 157 141 19 20
CARVEDILOL 147 147 20 23
GLIMEPIRIDE 142 142 21 32
TRAZODONE HCL 139 92 22 33
ALENDRONATE SODIUM 132 129 23 25
MELOXICAM 130 98 24 18
NAMENDA 125 125 25 58
SPIRONOLACTONE 121 111 26 44
LOSARTAN-HYDROCHLOROTHIAZIDE 118 118 27 30
NABUMETONE 115 109 28 84
LANTUS 114 102 29 59
ATORVASTATIN CALCIUM 101 78 30 14
HYDROCHLOROTHIAZIDE 96 92 31 10
ADVAIR DISKUS 87 87 32 52
CYMBALTA 86 85 33 34
PREDNISONE 86 69 33 36
ISOSORBIDE MONONITRATE ER 84 76 35 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 57 36 37
AMITRIPTYLINE HCL 78 58 R 37 116
ROPINIROLE HCL 76 76 38 66
CITALOPRAM HBR 70 60 39 21
HUMALOG 69 62 40 127
CRESTOR 68 67 41 39
DIGOXIN 67 67 42 128
PRAVASTATIN SODIUM 67 67 42 22
BUPROPION HCL SR 62 48 44 91
DICLOFENAC SODIUM 61 50 45 76
ATENOLOL 61 61 45 19
MORPHINE SULFATE ER 61 37 S2 45 43
NEXIUM 60 56 48 65
POLYETHYLENE GLYCOL 3350 59 46 49 31
CLOPIDOGREL 58 51 50 38
FLUTICASONE PROPIONATE 57 52 51 27
ACTOS 56 56 52 101
HUMALOG MIX 75-25 55 46 53 148
LYRICA 52 41 54 68
BYSTOLIC 52 40 54 61
DILTIAZEM 24HR CD 51 51 56 158
RAMIPRIL 51 39 56 89
ZOLPIDEM TARTRATE 51 45 56 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.